Smithfield Trust’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1080 |
|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1090 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1096 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1029 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1047 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1049 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1057 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1025 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1027 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1068 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1012 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1022 |
|
|
2023
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 974 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1010 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1066 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1081 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1083 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1104 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 1080 |
|
|
2020
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 1075 |
|
|
2020
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 1063 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 1011 |
|
|
2020
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 906 |
|
|
2019
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 932 |
|
|
2019
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 977 |
|
|
2019
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 962 |
|
|
2019
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 895 |
|
|
2018
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 921 |
|
|
2018
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 956 |
|
|
2018
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 971 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 1023 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 1086 |
|
|
2017
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 788 |
|
|
2017
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 789 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 774 |
|
|
2016
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 772 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 805 |
|
|
2016
Q2 | $0 | Buy |
+1
| New | +$458 | ﹤0.01% | 818 |
|
Other funds holding KYNB
AC
BC
Smithfield Trust's KYNB Position: Q2 2026 in Review
Smithfield Trust held its Kyntra Bio (KYNB) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1080.
Smithfield Trust first reported a position in KYNB in Q2 2016 and has held it in 41 quarters since. The position peaked at $2K in Q1 2019. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.
- Smithfield Trust held 1 share of Kyntra Bio worth $0 as of Q2 2026.
- Smithfield Trust left its Kyntra Bio share count unchanged in Q2 2026.
- Kyntra Bio made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #1080 holding.
- Smithfield Trust first reported a position in Kyntra Bio in Q2 2016 and has held it in 41 quarters since.
- Smithfield Trust's Kyntra Bio position peaked at $2K in Q1 2019.
- 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.
Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.